Efficacy and safety of vitamin D supplementation in asthmatic children: a randomized controlled trial (ESDAC trial)
- Conditions
- Health Condition 1: null- Persistent asthma
- Registration Number
- CTRI/2015/09/006214
- Lead Sponsor
- INDIAN COUNCIL OF MEDICAL RESEARCH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 250
1)Children 4 to 12 years of age.
2)Physician diagnosed persistent asthma receiving regular inhaled corticosteroids. All (mild, moderate, and severe) persistent asthma receiving any dose of inhaled steroids will be eligible for study. Both old and new cases of persistent asthma and all types (atopic, non-atopic) of persistent asthma will be included for study.
(3) Vitamin D levels < 20 ng/ml
1)Clinically having rickets.
2)Children with chronic diseases like chronic renal failure, chronic liver disease, or any bone disease.
3)Mental retardation.
4)Receiving vitamin D supplementation.
5)Received a mega dose of vitamin D (3 lac-6 lac units) in last one month.
6)Any patient that in the opinion of investigators is unlikely to follow up.
7)Participation in any other clinical trial within 3 months prior to enrolment
8)Parents not giving consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method